Osaze Udeagbala, MD, MBA, is Business Development Transactions Lead (GI) at Takeda Pharmaceuticals. In this role, he drives opportunity identification, diligence, strategy, and transactions for the Gastroenterology therapeutic area, with a primary focus on inflammation, fibrosis, and motility.

While completing his medical training, Osaze was a research fellow at Longitude Capital, an early-stage biotech VC, where he focused on neurodegeneration landscaping. He was an intern with Takeda’s Center for External Innovation during his MBA, where he co-led a non-viral delivery strategy exercise and supported deal flow in externalization. He also carries experience from Boston Consulting Group and Gates Medical Research Institute.

Osaze received his MD from New York University, MBA from MIT Sloan School of Management, and his Bachelor’s in Engineering summa cum laude from Cooper Union in New York.